Evidence suggests that amyloid-beta (Aβ) depositions parallel sleep deficits in Alzheimer's
disease (AD). However, it remains unknown whether impaired sleep and changes in plasma …

Alzheimer's disease is the most common type of dementia which has both cognitive and non-
cognitive disabilities. Recent research has proved that sleep deprivation and insomnia have …

Alzheimer's Disease (AD), characterized by abnormally phosphorylated tau, Paired Helical
Filaments (PHFs), Neurofibrillary Tangles (NFTs), deregulated mammalian Target Of …

The growing interest in the preclinical stage of Alzheimer's disease (AD) led investigators to
identify modifiable risk and predictive factors useful to design early intervention strategies …

Polysomnography (PSG) studies of sleep changes in Alzheimer's disease (AD) have
reported but not fully established the relationship between sleep disturbances and AD. To …

Recent findings indicate that poor sleep is a risk factor for brain Aβ deposition, and Aβ
deposition contributes to sleep disruption. Through the conduct of more mechanistic studies …

Sleep disturbance is a common symptom in patients with various neurodegenerative
diseases, including Alzheimer's disease (AD), and it can manifest in the early stages of the …

Alzheimer's disease (AD) is an untreatable, multifactorial, chronic, progressive,
neurodegenerative disorder, which is the principal cause of dementia throughout the world …

Cognitive decline in old age, particularly impairments associated with neurodegenerative
dementias such as Alzheimer disease (AD), represents one of the largest public health and …

As the older segment of our population grows, cognitive decline and dementia will increase
in prevalence, with Alzheimer's disease (AD) as the cause in most cases. Until a cure exists …